TY - JOUR
AU1 - Rašlová, K.
AU2 - Dobiášová, M.
AU3 - Nagyová, A.
AU4 - Fábry, R.
AU5 - Rauchová, H.
AU6 - Dušinská, M.
AB - 
Objectives: This study was conducted to examine a complex effect of ciprofibrate therapy in patients with atherogenic lipoprotein phenotype.
TI - Ciprofibrate treatment in patients with atherogenic  lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage
JF - European Journal of Clinical Pharmacology
DO - 10.1007/s002280050537
DA - 1998-12-15
UR - https://www.deepdyve.com/lp/springer-journals/ciprofibrate-treatment-in-patients-with-atherogenic-lipoprotein-fGRaZ4eIb0
SP - 697
EP - 699
VL - 54
IS - 10
DP - DeepDyve
ER -